Oct 12, 2020 8:00 am EDT Volition Veterinary Diagnostics Development LLC to Present Product Data Regarding its Nu.Q™ Vet Cancer Screening Test at the 2020 VCS Virtual Annual Conference
Aug 13, 2020 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update
Aug 10, 2020 7:30 am EDT VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update
Jul 14, 2020 6:00 am EDT Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test
Jun 25, 2020 8:45 am EDT VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes
May 27, 2020 8:45 am EDT Volition Announces Cameron Reynolds, President and Chief Executive Officer Invited as Presenter at Maxim's COVID-19 Virtual Conference
May 22, 2020 4:01 pm EDT VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock
